TY - JOUR T1 - The impact of COVID-19 shielding on the wellbeing, mental health and treatment adherence of adults with cystic fibrosis JF - Future Healthcare Journal JO - Future Healthc J SP - e47 LP - e49 DO - 10.7861/fhj.2020-0205 VL - 8 IS - 1 AU - Kristina A Westcott AU - Frances Wilkins AU - Amelia Chancellor AU - Alan Anderson AU - Simon Doe AU - Carlos Echevarria AU - Stephen J Bourke Y1 - 2021/03/01 UR - http://www.rcpjournals.org/content/8/1/e47.abstract N2 - People with cystic fibrosis (CF) were advised to undertake ‘shielding’ at home during the COVID-19 pandemic to reduce their risk of infection. We studied the impact shielding had on their wellbeing, mental health (GAD-7 and PHQ-9 scores) and adherence to treatment. 63 (46%) of 137 people surveyed responded (19 anonymously; 44 gave their identity). Most (94%) adhered to shielding advice ‘all the time/often’ but many (76%) found this difficult with disruption of their routines, relationships and exercise habits. Treatment adherence rates were high and continued during COVID-19. Depression scores were low and remained stable. Clinically significant anxiety rates rose from 27% pre-COVID-19 to 54% during COVID-19 and seven patients requested a psychology consultation from this study. There is a need to monitor the wellbeing of people with CF during the ongoing COVID-19 pandemic. ER -